Shu-Yang Xie (Shuyang Xie)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Venues

Thoracic cancer

International journal of nanomedicine

Communications biology

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Huan-Huan Shen, Jie-Fei Peng, Ran-Ran Wang, Ping-Yu Wang, Jia-Xiang Zhang, Hong-Fang Sun, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, You-Jie Li, Guang-Bin Sun, Shu-Yang Xie
IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8 + T, and CD4 + T Cells. International journal of nanomedicine 19 (2024)
Dong-Min Liang, You-Jie Li, Jia-Xiang Zhang, Huan-Huan Shen, Chun-Xia Wu, Ning Xie, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, Hong-Fang Sun, Qin Wang, Jian Yang, Xiao-Hua Li, Ping-Yu Wang, Shu-Yang Xie
m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. Communications biology 7 (1) (2024)
Huan-Huan Shen, Jie-Fei Peng, Ran-Ran Wang, Ping-Yu Wang, Jia-Xiang Zhang, Hong-Fang Sun, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, You-Jie Li, Guang-Bin Sun, Shu-Yang Xie
IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8 + T, and CD4 + T Cells. International journal of nanomedicine 19 (2024)
Meng-Ru Zhang, Lin-Lin Fang, Yang Guo, Qin Wang, You-Jie Li, Hong-Fang Sun, Shu-Yang Xie, Yan Liang
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy. International journal of nanomedicine 19 (2024)
Dong-Min Liang, You-Jie Li, Jia-Xiang Zhang, Huan-Huan Shen, Chun-Xia Wu, Ning Xie, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, Hong-Fang Sun, Qin Wang, Jian Yang, Xiao-Hua Li, Ping-Yu Wang, Shu-Yang Xie
m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. Communications biology 7 (1) (2024)
Meng-Ru Zhang, Lin-Lin Fang, Yang Guo, Qin Wang, You-Jie Li, Hong-Fang Sun, Shu-Yang Xie, Yan Liang
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy. International journal of nanomedicine 19 (2024)
Dong-Min Liang, You-Jie Li, Jia-Xiang Zhang, Huan-Huan Shen, Chun-Xia Wu, Ning Xie, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, Hong-Fang Sun, Qin Wang, Jian Yang, Xiao-Hua Li, Ping-Yu Wang, Shu-Yang Xie
m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. Communications biology 7 (1) (2024)
Rui Liu, Han Zhang, Jiaxuan Xin, Shu-Yang Xie, Fei Jiao, You-Jie Li, Meng-Yuan Chu, Junming Qiu, Yun-Fei Yan
Novel circular RNA hsa_circ_0036683 suppresses proliferation and migration by mediating the miR-4664-3p/CDK2AP2 axis in non-small cell lung cancer. Thoracic cancer (2024)
Meng-Ru Zhang, Lin-Lin Fang, Yang Guo, Qin Wang, You-Jie Li, Hong-Fang Sun, Shu-Yang Xie, Yan Liang
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy. International journal of nanomedicine 19 (2024)
Dong-Min Liang, You-Jie Li, Jia-Xiang Zhang, Huan-Huan Shen, Chun-Xia Wu, Ning Xie, Yan Liang, Yan-Mei Li, Jiang-Nan Xue, Hong-Fang Sun, Qin Wang, Jian Yang, Xiao-Hua Li, Ping-Yu Wang, Shu-Yang Xie
m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. Communications biology 7 (1) (2024)
Jiaen Wu, Xuejia Han, Xiancong Yang, Youjie Li, Yan Liang, Guangbin Sun, Ranran Wang, Pingyu Wang, Shu-Yang Xie, Jiankai Feng, Hongfang Sun
MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thoracic cancer 14 (6) (2023)
Ying Zhang, Ran-Ran Wang, Rui Liu, Shu-Yang Xie, Fei Jiao, You-Jie Li, Jiaxuan Xin, Han Zhang, Zhenbo Wang, Yun-Fei Yan
Delivery of miR-3529-3p using MnO 2 -SiO 2 -APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A. Thoracic cancer (2023)
Rong Wang, Huanhuan Shen, Jiaxiang Zhang, Xiyan Li, Yang Guo, Zhenjun Zhao, Pingyu Wang, Ning Xie, Youjie Li, Guiwu Qu, Shu-Yang Xie
Dimethyl Bisphenolate Ameliorates Carbon Tetrachloride-Induced Liver Injury by Regulating Oxidative Stress-Related Genes. Molecules (Basel, Switzerland) 28 (24) (2023)
Jiaen Wu, Xuejia Han, Xiancong Yang, Youjie Li, Yan Liang, Guangbin Sun, Ranran Wang, Pingyu Wang, Shu-Yang Xie, Jiankai Feng, Hongfang Sun
MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thoracic cancer 14 (6) (2023)
Jiaen Wu, Xuejia Han, Xiancong Yang, Youjie Li, Yan Liang, Guangbin Sun, Ranran Wang, Pingyu Wang, Shu-Yang Xie, Jiankai Feng, Hongfang Sun
MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thoracic cancer (2023)
Rong Wang, Huanhuan Shen, Jiaxiang Zhang, Xiyan Li, Yang Guo, Zhenjun Zhao, Pingyu Wang, Ning Xie, Youjie Li, Guiwu Qu, Shu-Yang Xie
Dimethyl Bisphenolate Ameliorates Carbon Tetrachloride-Induced Liver Injury by Regulating Oxidative Stress-Related Genes. Molecules (Basel, Switzerland) 28 (24) (2023)
Yan Liang, Ping-Yu Wang, Ze-Yun Liu, Hong-Fang Sun, Qin Wang, Guang-Bin Sun, Xia Zhang, You-Jie Li, Shu-Yang Xie
Dual Stimuli-Responsive Micelles for Imaging-Guided Mitochondrion-Targeted Photothermal/Photodynamic/Chemo Combination Therapy-Induced Immunogenic Cell Death. International journal of nanomedicine 18 (2023)
Jiaen Wu, Xuejia Han, Xiancong Yang, Youjie Li, Yan Liang, Guangbin Sun, Ranran Wang, Pingyu Wang, Shu-Yang Xie, Jiankai Feng, Hongfang Sun
MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thoracic cancer 14 (6) (2023)
Yuan-Rong Liu, Dan-Dan Song, Dong-Min Liang, You-Jie Li, Yun-Fei Yan, Hong-Fang Sun, Mei-Ling Zhang, Jin-Xia Hu, Yu-Long Zhao, Yan Liang, Yan-Mei Li, Zhen Yang, Ran-Ran Wang, Hou-Feng Zheng, Pingyu Wang, Shu-Yang Xie
Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession. Cell death discovery 8 (1) (2022)
Pei-Kuan Cong, Wei-Yang Bai, Jin-Chen Li, Meng-Yuan Yang, Saber Khederzadeh, Si-Rui Gai, Nan Li, Yu-Heng Liu, Shi-Hui Yu, Wei-Wei Zhao, Jun-Quan Liu, Yi Sun, Xiao-Wei Zhu, Pian-Pian Zhao, Jiang-Wei Xia, Peng-Lin Guan, Yu Qian, Jian-Guo Tao, Lin Xu, Geng Tian, Ping-Yu Wang, Shu-Yang Xie, Mo-Chang Qiu, Ke-Qi Liu, Bei-Sha Tang, Hou-Feng Zheng
Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project. Nature communications 13 (1) (2022)
Yu-Long Zhao, Jia-Xiang Zhang, Juan-Juan Yang, Yu-Bo Wei, Jie-Fei Peng, Chang-Jin Fu, Min-Hua Huang, Rong Wang, Ping-Yu Wang, Guang-Bin Sun, Shu-Yang Xie
MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer. Thoracic cancer 13 (6) (2022)
Jiefei Peng, Ranran Wang, Wanru Sun, Minhua Huang, Rong Wang, Youjie Li, Pingyu Wang, Guangbin Sun, Shu-Yang Xie
Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer. Biomaterials science 9 (19) (2021)
Wanru Sun, Hui Yu, Deqiang Wang, Youjie Li, Baocheng Tian, Shuang Zhu, Ping-Yu Wang, Shu-Yang Xie, Ranran Wang
MnO2 nanoflowers as a multifunctional nano-platform for enhanced photothermal/photodynamic therapy and MR imaging. Biomaterials science 9 (10) (2021)
Qian Zhang, Yun-Fei Yan, Qing Lv, You-Jie Li, Ran-Ran Wang, Guang-Bin Sun, Li Pan, Jin-Xia Hu, Ning Xie, Can Martin Zhang, Bao-Cheng Tian, Fei Jiao, Sen Xu, Ping-Yu Wang, Shu-Yang Xie
miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation. Cell death & disease 12 (8) (2021)
Fei Jiao, Ruoyu Guo, Jacques S Beckmann, Zhonghai Yan, Yun Yang, Jinxia Hu, Xin Wang, Shu-Yang Xie
Great future or greedy venture: Precision medicine needs philosophy. Health science reports 4 (3) (2021)
Meng-Meng Ren, Sen Xu, Yu-Bo Wei, Juan-Juan Yang, Ya-Nan Yang, Shan-Shan Sun, You-Jie Li, Ping-Yu Wang, Shu-Yang Xie
Roles of HOTAIR in lung cancer susceptibility and prognosis. Molecular genetics & genomic medicine 8 (7) (2020)
Chang-Jin Fu, Jing Cong, Shan-Shan Sun, Meng-Meng Ren, Shu-Yang Xie, Ping-Yu Wang
Diagnostic roles of HOX transcript antisense intergenic RNA in cancer. Asia-Pacific journal of clinical oncology 17 (2) (2020)

Shu-Yang Xie.css-eqlu8i{font-size:small;padding-left:4px;} (Shuyang Xie)

Publication Activity (10 Years)

Top Topics

Top Venues

Shu-Yang Xie (Shuyang Xie)